Accretion Pharmaceuticals’ IPO to open on May 14 2025; Price band fixed at ₹96-101
Express Pharma
MAY 11, 2025
Accretion Pharmaceuticals, an Ahmedabad-headquartered pharmaceuticals manufacturer, announced that its initial public offering (IPO) will open for subscription on Wednesday, May 14, 2025. The anchor portion will be opened on Tuesday, May 13, 2025, and the issue will conclude on Friday, May 16, 2025. The company intends to raise 29.75 crore from the offering and aims to be listed on the NSE Emerge platform.
Let's personalize your content